Save the date! Assessing and Reporting Environmental Risk for Human Medicinal Products throughout Development
Thursday, September 15, 2-3 pm CET
The Sustainability (SUS) and Pharmacovigilance (PV) Special Interest Groups (SIGs) will present a joint webinar on the topic of Assessing and Reporting Environmental Risk for Human Medicinal Products throughout Development, by Diana Radovan, Plusultra Pharma GmbH and Liron Sarid-Krebs, Biopharma Excellence, a PharmaLex company.
Read more details in EMWA's webinar programme webpage.